Trends, Charts and Exclusive Opinion
Three SmallCaps that Provide Opportunity
NVAX: A Focused Pipeline on Influenza and Shingles
CREG: Changes from the OTCBB to the NASDAQ GM
JMBA: Strong Store Management Makes the Juicer Rise
First up this morning is Novavax Inc., (NVAX) http://www.novavax.com/ currently trading in the $2.59 range on 1.5 million shares daily. NVAX was trading in the $1 range a year ago and in late-April began a rally that lasted through the first week of Sept 09 and topping out in the $6 range (with a very short spike into the $8 range). NVAX dropped during Sept towards the $3 level and then found $4 in Oct. NVAX then trailed-off for the next 5-Months to its current level. NVAX has a 52-week high of $7.79 set on 09-01-09.
NVAX is a pharma-development company whose drug candidates target pandemic influenza, including H1N1 and H5N1 strains; seasonal influenza; Respiratory Syncytial Virus; and Varicella Zoster Virus that causes shingles. At this price, NVAX is a long-term (1 Yr) �Buy� consideration for me. Here�s why...
NVAX has a focused pipeline that affects two big problems: influenza and shingles. On March 24, NVAX reported positive results from Phase I of its two-phase clinical study in Mexico for its H1N1 vaccine. NVAX is now officially seeking Mexican regulatory approval to market the vaccine. The trial is being conducted at the Mexican Institute of Social Security and includes 1,000 healthy volunteers aged 18 to 64. Earlier this month, the company completed! enrollm ent of more than 3,500 volunteers for the second phase of the study. NVAX is conducting the Mexican studies in a partnership with Avimex Labs. In addition to the H1N1 vaccine trials in Mexico, NVAX has clinical trials under way in the U.S. for its seasonal flu vaccine.
NVAX 1-Year
----------------------------------------------------------------------
Sign-Up for Free to Receive Future Commentary and
Trading Alerts on NVAX, CREG, and JMBA.
----------------------------------------------------------------------
Next up this morning is China Recycling Energy Corporation (CREG) http://www.creg-cn.com currently trading in the $5.65 range. CREG was trading in the 50 cent range a year ago and in June of 09 found a floor at $1. CREG then began a long, steady ascent beginning in the summer which carried it to $2 in Sept. As the ascent continued, CREG found $4 at the end of 2009 and in the last 10-weeks has continued to climb into its current range. GREG switched from the OTCBB to the NASDAQ Global Market exchange on March 22. The boost is reflective in the share value.
�We expect the new listing on NASDAQ will provide greater exposure and opportunities for CREG and its shareholders,� said Mr. Guohua Ku, Chairman and CEO of CREG. It did. CREG is a long-term �Buy� cons ideration for me because of its business; recycling industrial by-products for steel mills, cement factories and coke plants in China. In FY 2009, CREG revenues increased 130% to $44.2 million, up from $19.2 Million in 2008 and in 2010 guidance, CREG management expects revenues in the range of $68-72 million.
Finally this morning is Jamba Inc., (JMBA) http://www.jambajuice.com/ currently trading in the $2.35 range on over a half a million shares daily. JMBA was trading at 50 cents a year ago. Like China Recycling, JMBA then staged a long, slow, steady climb. JMBA reached a $1 through the summer of 09, often toying with $1.25 and made a big surge in Sept-Oct above $2. The stock then dipped a little before it found a 4-Month floor at $1.75. This month, JMBA shot-up into the $2.25 to $2.50 range. JMBA has a 52-week high of $2.48 set on 03-24-10 with current trailing twelve month revenues of $301+ million. Buy at the high? JMBA, because of its store management strength, is a Short-term (6 Mo) �Buy� consideration for me.
The best news coming from its recent Q4 ended December 29, is that JMBA opened one new franchise store and one new company-owned store, bringing the store count to 739 stores system-wide, of which 261 are franchise stores and 478 are company-owned stores. JMBA management also provided some guidance; the Company intends to complete refranchising of up to 150 company-owned stores started in 2009. A�notes:�Investors might see JMBA�as a cyclical venture so remember, juices sell a lot in the summer.��
If you'd like to receive further updates and any changes in our opinions of NVAX, CREG, and JMBA,�be sure to Sign-Up for the SCN Newsletter today! It's FREE.
No comments:
Post a Comment